AIDS drug discovery and development
McGowan, J.; Hoth, D.
Journal of Acquired Immune Deficiency Syndromes 2(4): 335-343
1989
ISSN/ISBN: 0894-9255 PMID: 2666639 Document Number: 346257
Document emailed within 1 workday
Related Documents
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282Kojima, H.; Okabe, T.; Nagano, T. 2013: Open innovation center for drug discovery: a research-supporting network for drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(6): 327-332
Fujita, Y. 2013: Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 89-95
Lucignani, G.; Bastianello, S. 2007: Pharmacological MRI: a biomarker in CNS drug discovery and development? Functional Neurology 22(2): 71-73
Schacter, L.P.; Anderson, C.; Canetta, R.M.; Kelley, S.; Nicaise, C.; Onetto, N.; Rozencweig, M.; Smaldone, L.; Winograd, B. 1992: Drug discovery and development in the pharmaceutical industry Seminars in Oncology 19(6): 613-621
Yamada, H. 2013: Application of translational research to drug discovery and development Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(3): 121
Amanfu, R.K.; Saucerman, J.J. 2011: Cardiac models in drug discovery and development: a review Critical Reviews in Biomedical Engineering 39(5): 379-395
Lowe, J.A.; Jones, P.; Wilson, D.M. 2009: The importance of target validation in drug discovery and development Current Opinion in Drug Discovery and Development 12(5): 581-584
Srivastava, P.; Tiwari, A. 2017: Critical Role of Computer Simulations in Drug Discovery and Development Current Topics in Medicinal Chemistry 17(21): 2422-2432
Nassar, A-Eldin.F.; Lopez-Anaya, A. 2004: Strategies for dealing with reactive intermediates in drug discovery and development Current Opinion in Drug Discovery and Development 7(1): 126-136
2006: NIAID researchers make key discovery in development of TB drug candidate Journal of investigative medicine: the official publication of the American Federation for Clinical Research 54(2): 53-54
Wunder, A.; Thiele, A.; Koslowski, M.; Gantner, F.; Niessen, H. 2014: Nuclear imaging to support anti-inflammatory drug discovery and development Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 2014
Brown, A.G. 1986: Clavulanic acid, a novel beta-lactamase inhibitor--a case study in drug discovery and development Drug Design and Delivery 1(1): 1-21
Shen, Y. 2007: Discovery on Target 2007--CHI's Fifth Annual Conference. RNAi for Drug Discovery and Therapeutics IDrugs: the investigational drugs journal 10(12): 848-850
Young, S.S. 1999: Discovery 99: accelerate and improve the drug discovery process. 26-29 April 1999, San Diego, CA, USA IDrugs: the investigational drugs journal 2(7): 648-649
Harrigan, G.G. 2006: Metabolic profiling--IBC's inaugural meeting. Using metabolomics to accelerate drug discovery and development. 14-15 November 2005, Durham, NC, USA IDrugs: the investigational drugs journal 9(1): 28-31
Kashyap, A.; Singh, P.Kumar.; Silakari, O. 2018: Counting on Fragment Based Drug Design Approach for Drug Discovery Current Topics in Medicinal Chemistry 18(27): 2284-2293
Emilien, G.; Maloteaux, J.M. 1998: Pharmacological management of epilepsy. Mechanism of action, pharmacokinetic drug interactions, and new drug discovery possibilities International Journal of Clinical Pharmacology and Therapeutics 36(4): 181-194
Armetti, L. 1999: Round table: The Italian Pharmacology Society and the drug industry: new processes in drug discovery and the contribution of universities Bollettino chimico farmaceutico 138(11): 596-598
Bittner, B.; Mountfield, R.J. 2002: Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters Current Opinion in Drug Discovery and Development 5(1): 59-71